PERRY MICHAEL S Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$200,002.00
Insider Sells Quantity
13
Insider Sells Sum
$10.06M

Insider Activity of PERRY MICHAEL S

According to the SEC Form 4 filings, PERRY MICHAEL S, being in a position of

  1. director at Arrowhead Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 27850 shares for $2M,
    over all time since 2019-09-09, has bought 0 shares, and sold 257350 shares for $9.33M.

Biography of PERRY MICHAEL S

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,004,4182100

Comparison of Insiders on Amount of Buys and Sells

2026-08-18SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
11,600
0.0082%
$87.30$1.01M-25.08%
2025-12-05SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
16,250
0.0117%
$61.03$991,738+13.2%
2022-02-24SaleAVITA Medical, Inc.
RCEL
Chief Executive Officer
10,812
0.0423%
$8.74$94,497-27.15%
2022-01-03SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
4,500
0.0039%
$64.71$291,192-43.25%
2021-09-01SaleAVITA Medical, Inc.
RCEL
Chief Executive Officer
11,220
0.0447%
$20.68$232,030-57.95%
2021-06-02SaleAVITA Medical, Inc.
RCEL
Chief Executive Officer
23,000
0.0925%
$17.33$398,590-22.22%
2021-01-04SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
4,000
0.0039%
$76.09$304,360-7.79%
2020-09-16SaleAVITA Medical, Inc.
RCEL
Chief Executive Officer
9,000
0.0407%
$27.41$246,690-26.83%
2020-09-15SaleAVITA Medical, Inc.
RCEL
Chief Executive Officer
23,769
0.1083%
$27.23$647,230-25.65%
2020-09-14SaleAVITA Medical, Inc.
RCEL
Chief Executive Officer
15,092
0.0697%
$26.99$407,333-23.95%
2020-09-11SaleAVITA Medical, Inc.
RCEL
Chief Executive Officer
20,000
0.0923%
$26.02$520,400-21.14%
2020-09-10SaleAVITA Medical, Inc.
RCEL
Chief Executive Officer
7,128
0.0335%
$26.26$187,181-20.44%
2020-05-12SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
36,000
0.0352%
$35.83$1.29M+73.46%
2019-09-11SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
85,000
0.085%
$30.00$2.55M+28.36%
2019-09-09SaleArrowhead Pharmaceuticals, Inc.
ARWR
director
100,000
0.1037%
$28.90$2.89M+38.15%
2018-03-22PurchaseArmata Pharmaceuticals, Inc.
ARMP
director
181,820
1.2965%
$1.10$200,002-16.38%
2017-09-19PurchaseArmata Pharmaceuticals, Inc.
ARMP
director
105,015
–
$0$0+11.11%
2017-06-29PurchaseArmata Pharmaceuticals, Inc.
ARMP
director
5,757
–
$0$0+43.42%
Total: 18
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.